We screened samples from four COVID-19 patients and their donors who recovered from COVID-19 (Group 2 and 3, Table 1) against SARS-CoV-2 S, S2, RBD, HR2 and N before and after CP transfusion. This evidence concerns the gene CP and COVID-19.